Abstract:Rationale: Wear particle-induced periprosthetic osteolysis (PPO) is a common long-term complication of total joint arthroplasty, and represents the major cause of aseptic loosening and subsequent implant failure. Previous studies have identified the central role of osteoclast-mediated bone resorption in the pathogenesis of PPO. Thus, therapeutic approaches of inhibiting osteoclast formation and activity are considered to be of great potential to prevent and treat this osteolytic disease. Hedgehog (Hh) signaling has been shown to play an important role in promoting osteoblast differentiation and bone formation. While Hh signaling is also implicated in regulating osteoclastogenesis, whether it can directly inhibit osteoclast differentiation and bone resorption remains controversial. Moreover, its potential therapeutic effects on PPO have never been assessed. In this study, we explored the cell-autonomous role of Hh signaling in regulating osteoclastogenesis and its therapeutic potential in preventing wear particle-induced osteolysis. Methods: Hh signaling was activated in macrophages by genetically ablating Sufu in these cells using LysM-Cre or by treating them with purmorphamine (PM), a pharmacological activator of Smoothened (Smo). In vitro cell-autonomous effects of Hh pathway activation on RANKL-induced osteoclast differentiation and activity were evaluated by TRAP staining, phalloidin staining, qPCR analyses, and bone resorption assays. In vivo evaluation of its therapeutic efficacy against PPO was performed in a murine calvarial model of titanium particle-induced osteolysis by mu CT and histological analyses. Mechanistic details were explored in RANKL-treated macrophages through Western blot analyses. Results: We found that Sufu deletion or PM treatment potently activated Hh signaling in macrophages, and strongly inhibited RANKL-induced TRAP(+) osteoclast production, F-actin ring formation, osteoclast-specific gene expression, and osteoclast activity in vitro. Furthermore, we found that Sufu deletion or PM administration significantly attenuated titanium particle-induced osteoclast formation and bone loss in vivo. Our mechanistic study revealed that activation of Hh signaling suppressed RANKL-induced activation of JNK pathway and downregulated protein levels of two key osteoclastic transcriptional factors, c-Fos and its downstream target NFATc1. Conclusions: Both genetic and pharmacological activation of Hh signaling can cell-autonomously inhibit RANKL-induced osteoclast differentiation and activity in vitro and protect against titanium particle-induced osteolysis in vivo. Mechanistically, Hh signaling hinders osteoclastogenesis partly through suppressing the JNIQc-Fos-NFATc1 cascade. Thus, Hh signaling may serve as a promising therapeutic target for the prevention and treatment of PPO and other osteolytic diseases.

The fibroblast expression of RANKL in CoCrMo-particle-induced osteolysis is mediated by ER stress and XBP1s

The inhibition of RANKL expression in fibroblasts attenuate CoCr particles induced aseptic prosthesis loosening via the MyD88-independent TLR signaling pathway.

Particle-Induced Osteolysis Mediated by Endoplasmic Reticulum Stress in Prosthesis Loosening

Endoplasmic Reticulum Stress-Mediated Inflammatory Signaling Pathways Within the Osteolytic Periosteum and Interface Membrane in Particle-Induced Osteolysis

Is there another possible approach to inhibit wear particles-induced inflammatory osteolysis?

Particle-induced osteolysis is mediated by endoplasmic reticulum stress-associated osteoblast apoptosis

Substance P Enhanced Titanium Particles-Induced RANKL Expression in Fibroblasts from Periprosthetic Membrane

Fibroblast-Like-Synoviocytes Mediate Secretion of Pro-Inflammatory Cytokines via ERK and JNK MAPKs in Ti-Particle-Induced Osteolysis

Kaempferol attenuates particle-induced osteogenic impairment by regulating ER stress via the IRE1α-XBP1s pathway

Endoplasmic reticulum stress-induced apoptosis of osteoblasts within the osteolytic craniums

Particles-induced Osteoblast Apoptosis and Inflammation Mediated by Endoplasmic Reticulum in a Murine Model of Periprosthestic Osteolysis

Bone cement particles promote fibroblast-supported osteolysis

Autophagy Mediated CoCrMo Particle-Induced Peri-Implant Osteolysis by Promoting Osteoblast Apoptosis.

Fibroblastic Stromal Cells Promote Periprosthetic Osteolysis

[Role and mechanism of endoplasmic reticulum stress response induced by wear particles in osteolysis]

Alendronate Stimulates Osteoprotegerin Expression in Fibroblasts from Periprosthetic Membrane.

The Recombinant Protein EphB4-Fc Changes the Ti Particle-Mediated Imbalance of OPG/RANKL Via EphrinB2/EphB4 Signaling Pathway and Inhibits the Release of Proinflammatory Factors in Vivo.

Sophocarpine Attenuates Wear Particle‐induced Implant Loosening by Inhibiting Osteoclastogenesis and Bone Resorption Via Suppression of the NF‐κB Signalling Pathway in a Rat Model

Molecular biological mechanism of osteolysis induced by titanium wear particles of artificial joint

TiAl6V4 Particles Promote Osteoclast Formation Via Autophagy-Mediated Downregulation of Interferon-Beta in Osteocytes

Genetic and pharmacological activation of Hedgehog signaling inhibits osteoclastogenesis and attenuates titanium particle-induced osteolysis partly through suppressing the JNK/c-Fos-NFATc1 cascade.